Miriam,
I received this in my email and sent it onto George Turner
George suggested I put a link in the forum as others may be interested.
Do you think UCL will be ok with adding the link when it's coming from a different support region of the world
Miriam if you think its ok open it up to the forum please ?
I will not be offended if its not appropriate.
TTR Amyloidosis - Patient Webinar
We are hosting a patient webinar on
Thursday, September 10, 2015,
by Giampaolo Merlini, MD.
TTR Amyloidosis - What Every Patient Must Know
12pm - 1pm US Eastern
11am - 12pm US Central
10am - 11am US Mountain
9am - 10am US Pacific
4pm - 5pm GMT
Go HERE to register
http://online.krm.com/iebms/reg/reg_p1_form.aspx?oc=10&ct=00902758&eventid=22917This will be a patient-focused webinar for those affected by this type of amyloidosis. New information will be shared regarding symptoms, diagnosis and treatment options.
Presented by
Giampaolo Merlini received his medical degree and specialized in Hematology and in Laboratory Medicine at the University of Pavia. He was trained by Prof. Jan Waldenström in the study of monoclonal gammopathies. He is Professor of Clinical Biochemistry and the Director of the Center for Research and Treatment of Systemic Amyloidosis, Department of Molecular Medicine, University of Pavia, Italy. He is also the past President of the International Society of Amyloidosis and member of the Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine. His research focuses on the investigation of the molecular mechanisms of systemic amyloidosis and the development of novel therapies, as well as on the discovery and validation of biomarkers in the management of monoclonal gammopathies.
Dr. Merlini has served as both a member of the Board of Directors and the Scientific Advisory Board of the Amyloidosis Foundation since 2010.
Summary
This will be a patient-focused webinar for those affected by this type of amyloidosis. New information will be shared regarding:
Symptoms
Diagnosis
Treatment options
Thank you to Alnylam for sponsoring this educational webinar.
Everything we do is with patients in mind
The Amyloidosis Foundation is a non-profit organization
Supporting patients and families while promoting research,
education and awareness of amyloidosis
www.amyloidosis.org 